Quantitative phase digital holographic microscopy combined with stem cell technology for identifying cell biomarkers of neurodevelopmental brain disorders including schizophrenia (Conference Presentation)

Abstract

The recent developments in stem cell biology especially the generation of induced pluripotent stem cells (iPSCs) has made possible the development of in vitro cellular models of developmental brain disorders including schizophrenia. Within this framework, we will present how quantitative phase imaging and in particular quantitative phase digital holographic microscopy (QP-DHM), as a label-free technique is able to study these in vitro cellular models and identify both some pathophysiological processes and cell biomarkers related to developmental brain disorders. This will be illustrated by the exploration with QP-DHM of human neuronal networks derived from iPSCs coming from patients suffering from schizophrenia.